These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38237307)

  • 1. Is routine gastrointestinal endoscopy required in every woman with mucinous ovarian cancer? An analysis of survival rates and metastatic tumours in a cancer centre.
    Katsanevakis E; Addo-Yobo W; Bharathan B; Loona A; Gan C; Nunns D; Gajjar K
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():105-110. PubMed ID: 38237307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of stage III mucinous and serous ovarian cancer: a case-control study.
    Firat Cuylan Z; Karabuk E; Oz M; Turan AT; Meydanli MM; Taskin S; Sari ME; Sahin H; Ulukent SC; Akbayir O; Gungorduk K; Gungor T; Kose MF; Ayhan A
    J Ovarian Res; 2018 Oct; 11(1):91. PubMed ID: 30376858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline ovarian tumours: retrospective analysis of twenty-one cases.
    Saygili U; Uslu T; Erten O; Doğan E
    Eur J Gynaecol Oncol; 1998; 19(2):182-5. PubMed ID: 9611063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.
    Matsuo K; Machida H; Mandelbaum RS; Grubbs BH; Roman LD; Sood AK; Gershenson DM
    Gynecol Oncol; 2019 May; 153(2):230-237. PubMed ID: 30797590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of lymph node metastases in clinical early-stage mucinous and seromucinous ovarian carcinoma: a retrospective cohort study.
    van Baal J; Van de Vijver KK; Coffelt SB; van der Noort V; van Driel WJ; Kenter GG; Buist MR; Lok C
    BJOG; 2017 Feb; 124(3):486-494. PubMed ID: 27860146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of Patients With Mucinous Ovarian Carcinoma and Ovarian Metastases: A Population-Based Cancer Registry Study.
    Simons M; Ezendam N; Bulten J; Nagtegaal I; Massuger L
    Int J Gynecol Cancer; 2015 Sep; 25(7):1208-15. PubMed ID: 25978291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it necessary to perform routine appendectomy for mucinous ovarian neoplasms? A retrospective study and meta-analysis.
    Cheng A; Li M; Kanis MJ; Xu Y; Zhang Q; Cui B; Jiang J; Zhang Y; Yang X; Kong B
    Gynecol Oncol; 2017 Jan; 144(1):215-222. PubMed ID: 27889016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of lymphadenectomy and intra-operative tumor rupture on survival in early-stage mucinous ovarian cancers.
    Kim SR; Madariaga A; Hogen L; Vicus D; Covens A; Parra-Herran C; Lheureux S; Gien LT
    Int J Gynecol Cancer; 2023 May; 33(5):755-760. PubMed ID: 36914170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
    Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt KA; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; ; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim BG; Kim JW; Kim JH; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park SY; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; ; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ
    Clin Cancer Res; 2022 Dec; 28(24):5383-5395. PubMed ID: 36222710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of fertility-sparing surgery in young women with stage I endometrioid epithelial and mucinous ovarian cancer: A population-based analysis.
    Li J; Qiao H; Liu Y; Huang C; Cheng A; Lin Z; Wang L; Lu H
    Eur J Surg Oncol; 2024 Jan; 50(1):107276. PubMed ID: 38064863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival impact of capsule status in stage I ovarian mucinous carcinoma-A mulicentric retrospective study.
    Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():131-136. PubMed ID: 30685661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-malignant potential epithelial tumors of the ovary: a clinicopathological study.
    Hassan E; Koumantaki Y; Stefanaki K; Matalliotakis I; Koumantakis E
    Eur J Gynaecol Oncol; 1998; 19(2):170-2. PubMed ID: 9611060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is lymphadenectomy necessary in mucinous ovarian cancer? A single institution experience.
    Salgado-Ceballos I; Ríos J; Pérez-Montiel D; Gallardo L; Barquet-Muñoz S; Salcedo-Hernández R; Pérez-Plasencia C; Herrera LA; Cantú de León DF
    Int J Surg; 2017 May; 41():1-5. PubMed ID: 28315410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving population-based statistics for rare epithelial ovarian cancers.
    Matsuo K; Machida H; Matsuzaki S; Grubbs BH; Klar M; Roman LD; Sood AK; Gershenson DM; Wright JD
    Gynecol Oncol; 2020 Apr; 157(1):3-11. PubMed ID: 31954534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early stage primary ovarian mucinous carcinoma: Outcome-based clinicopathological study in comparison with serous carcinoma.
    Tian Q; Lu B; Ye J; Lu W; Xie X; Wang X
    J Int Med Res; 2016 Apr; 44(2):357-66. PubMed ID: 26880793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas.
    Matsuo K; Matsuzaki S; Maeda M; Rau AR; Yoshihara K; Tamura R; Shimada M; Machida H; Mikami M; Klar M; Roman LD; Wright JD; Sood AK; Gershenson DM
    JAMA Netw Open; 2023 Jun; 6(6):e2318602. PubMed ID: 37326992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer antigens 19.9 and 125 as tumor markers in patients with mucinous ovarian tumors.
    Santotoribio JD; Garcia-de la Torre A; Cañavate-Solano C; Arce-Matute F; Sanchez-del Pino MJ; Perez-Ramos S
    Eur J Gynaecol Oncol; 2016; 37(1):26-9. PubMed ID: 27048105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms.
    Elias KM; Labidi-Galy SI; Vitonis AF; Hornick JL; Doyle LA; Hirsch MS; Cramer DW; Drapkin R
    Gynecol Oncol; 2014 Feb; 132(2):328-33. PubMed ID: 24342438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
    Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical staging of apparent early-stage ovarian mucinous carcinoma.
    Yuan Z; Zhang Y; Cao D; Shen K
    World J Surg Oncol; 2022 Sep; 20(1):307. PubMed ID: 36153622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.